MMEDS Act of 2023
Latest action · Jan 24, 2023 Read twice and referred to the Committee on Finance.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJan 24, 2023
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Medical Manufacturing, Economic Development, and Sustainability Act of 2023 or the MMEDS Act of 2023
This bill provides incentives for relocating medical manufacturing facilities in the United States and for manufacturing medical products (i.e., drugs and devices) in economically distressed zones. Specifically, the bill allows a income tax credit for 40% of the sum of wages paid in a medical product manufacturing economically distressed zone, employee fringe benefit expenses, and depreciation and amortization allowances with respect to qualified medical product manufacturing facility property, and a credit for economically distressed zone products and services acquired by domestic medical product manufacturers..
The bill also directs the Department of Health and Human Services to study the extent to which the health of aging individuals and vulnerable populations have been disproportionately harmed by the COVID-19 (i.e., coronavirus disease 2019) pandemic and prior epidemics and pandemics.
Cosponsors
Members who signed on, in the order they did.
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Finance Committee | Referred Jan 24, 2023 |
Actions 2
Everything that happened, newest first.
- Jan 24, 2023Introduced in Senate
- Jan 24, 2023Read twice and referred to the Committee on Finance.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 1203 | MMEDS Act of 2021 | Reintroduction of | Apr 19, 2021 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to rescue domestic medical product manufacturing activity by providing incentives in economically distressed areas of the United States and its possessions.
- Short Title(s) as Introduced
- MMEDS Act of 2023
- Medical Manufacturing, Economic Development, and Sustainability Act of 2023
Subjects
Assigned by the Library of Congress. Policy area: Taxation.
- Aging
- Business expenses
- Business investment and capital
- Cardiovascular and respiratory health
- Community life and organization
- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- Economic development
- Emergency medical services and trauma care
- Government studies and investigations
- Health technology, devices, supplies
- Income tax credits
- Income tax deductions
- Industrial facilities
- Infectious and parasitic diseases
- Manufacturing
- Minority health
- Public-private cooperation
- Research administration and funding
- Research and development
- Taxation
- Unemployment
- Veterans' medical care
- Wages and earnings
Text 1
Each version as it was printed, newest first.
- Jan 24, 2023Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.